Newsletter

Pulmonary Arterial Hypertension (PAH)
Emerging therapies in the horizon strive to transform the PAH market landscape
PULMONARY ARTERIAL HYPERTENSION (PAH)

More Whitepapers / Newsletters

Emergence of E-Pharmacies Whitepaper
Emergence of E-Pharmacies: Cha...

In the past few years, online buying has become the easiest way to purchase products and services. The ever increasing users of the internet services have led to the blooming of the e-commerce sector...

Gaucher Disease Newsletter
Gaucher Disease

The most common lysosomal disease, Gaucher Disease is a result of lack of sufficient glucocerebrosidase (GCase), an enzyme required for the break-down of glucocerebroside thus causing a build-up in ar...

Adult Onset Still's Disease
Adult Onset Still's Disease

Affecting the entire body, Adult Onset Still's disease (AOSD) is a rare type of inflammatory arthritis that affects most people before the age of 45. The symptoms of the disease usually begin with a...

Duchenne Muscular Dystrophy Newsletter
Duchenne Muscular Dystrophy

A genetic disorder, Duchenne Muscular Dystrophy (DMD), is a progressive form of muscular dystrophy with a higher preponderance in males; however, in some rare cases, it can occur in females too. As pe...

Cancer Anorexia Market
Cancer Anorexia

Anorexia is the loss of the desire to eat, whereas cachexia results from the skeletal muscle mass in excess because of the weight loss. The reason for Anorexia can be Cancer, AIDS, a mental disorder (...